Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
Submitted by
admin
on October 17, 2021 - 10:57pm
Source:
Motley Fool
News Tags:
ChemoCentryx
Ocular Therapeutics
Axsome Therapeutics
Headline:
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street
snippet:
ChemoCentryx recently produced compelling trial data that led Wall Street analysts who follow the biotech to raise their price targets.
Ocular Therapeutix is a commercial-stage drugmaker that just earned a label expanding approval for its sole product, Dextenza.
Axsome Therapeutics is a clinical-stage company with two new drug applications under review at the FDA.
Do Not Allow Advertisers to Use My Personal information